Wanqiang Sheng

3PUBLICATIONS
5CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 21, 2024
Priming with LSD1 inhibitors promotes the persistence and antitumor effect of adoptively transferred T cells.

Fengqi Qiu, Peishan Jiang, Guiheng Zhang

|Nov 25, 2021
LSD1 inhibition sustains T cell invigoration with a durable response to PD-1 blockade.

Yi Liu, Brian Debo, Mingfeng Li

Pageof 1